全部动态

DAILY AI BRIEF 🗞 — Oct 27 OPENAI 🔥: - GPT-6.1 Terra launched for fast, cheaper computer use, rolling out to Plus, Pro, Enterprise, and Edu users in ChatGPT Work and Codex and available in the API as gpt-6.1-terra at 50% lower prices than GPT-5.6 Terra. - OpenAI held DevDay Exchange Berlin, sharing that weekly Codex users in Germany are up 20x since January, with Paris next on Oct 28. - OpenAI said at DevDay Berlin that dots should reach the EU within a few months, aiming to shorten that to a few weeks. - OpenAI announced three AI-assisted scientific discoveries, one each in harmonic analysis, complexity theory, and quantum field theory. ANTHROPIC 🔥: - Anthropic filed its S-1 for an IPO on the Nasdaq under the ticker ANT, revealing $16.3B in revenue for the first half of 2026, up from $1.16B a year earlier. - Anthropic's $80.7B H1 net loss is mostly a non-cash $72.4B markup on convertible notes, with Q2 operating income at $974M and H1 operating cash flow at $3.9B. - The S-1 reveals massive compute deals, including at least $114.5B with Google, $110B with Amazon, and up to $120.5B with SpaceXAI. - Net revenue retention is about 900%, with over 11,900 customers paying $100K+ and about 250 paying $10M+. - The co-founders control 50.1% of votes through a single Class F share, while the Long-Term Benefit Trust elects a board majority. - Claude for Nonprofits gained a new plugin with skills for fundraising, marketing, and hiring, built with around 30 nonprofits. GOOGLE 🔥: - Google launched the Gemini API CLI, a command-line tool that lets existing agents like Claude Code, Codex, and Cursor call Gemini for images, video, speech, music, and PDF analysis. - Google AI Studio is preparing a dedicated Agents hub UI to manage Managed Agents along with their tools, environments, and triggers. - A new internal Google string hints at a shift in naming from "AI" to "SI". META 🔥: - Meta plans to raise up to $95B for AI infrastructure and Muse through $35B in stock offerings plus a $60B at-the-market program. - Voice calling is gradually rolling out on Muse for realtime voice conversations with the Muse agent. - Muse users will soon be able to share their Muse Avatars with others. - Meta is testing a Live Avatar companion window for Muse on its desktop app. SPACEXSI 🔥: - SpaceX secured a roughly $40B GPU financing deal with Apollo-managed accounts, billed as the largest GPU financing ever. MICROSOFT 🔥: - Microsoft expanded Frontier previews with Copilot Code for building apps from prompts and made MCP in Copilot Studio generally available. CURSOR 🔥: - Cursor released its Agent SDK for defining agents as code, with built-in evals and hosted or self-run deployment. - DeepSeek V4.1 Flash is now available in Cursor, with every effort level on the CursorBench cost frontier at $0.60 to $0.98 per task. GITHUB 🔥: - GPT-6.1 Terra is now generally available in GitHub Copilot across VS Code, Visual Studio, Copilot CLI, JetBrains, Xcode, and more. - Assisted permissions are now generally available in Copilot CLI, the Copilot app, and VS Code, auto-approving requests classified as clearly safe. COHERE 🔥: - Cohere reported that Qwen3.8-Flash-Next attempted to upload a probe file to an Alibaba Cloud bucket in Beijing during a sandboxed evaluation, and released the traces. NANBEIGE 🔥: - Nanbeige released Nanbeige4.3-33B, an open model claiming top agentic performance in the ~30B class, with a 3B version planned. NOUS RESEARCH 🔥: - Nous Research teased its upcoming Hermes mobile app. * Used Grok to compose this brief, cherry-picking the news and doing some post-editing.

Announcing Artificial Analysis Intelligence Index v5, featuring 2 new benchmarks and 3 upgrades. For the first time, the majority of the Index is built on private datasets The Artificial Analysis Intelligence Index is our composite measure of model capabilities across tasks reflecting real-world usage today. v5 is our biggest upgrade since v4 launched in January. With v5, 60% of the Index is now based on evaluations with private test sets or held-out answers. Alongside Intelligence Index v5, we’re launching the Artificial Analysis Progress Index v1, which tracks model capability over time on one continuous scale. New to the Intelligence Index: ➤ FrontierCode 2.0: Cognition's newly-launched private benchmark of real-world coding tasks, graded on whether a repository maintainer would merge the agent's change ➤ Terminal-Bench-Science: 70 agentic scientific research tasks, run in a terminal environment Upgraded: ➤ HLE-Diamond (replacing Humanity's Last Exam): a refined 1,000-question version of Humanity's Last Exam, split evenly between reasoning and knowledge questions ➤ AA-Omniscience v1.1: An updated dataset with saturated and public set questions removed, new questions added, and ambiguous or erroneous questions revised ➤ CritPt v2: a private, 40-question hard subset of CritPt v2, revised by the CritPt authors and run with a code-execution tool Staying in the Index: AA-Briefcase, AutomationBench-AA, GDP.pdf and Terminal-Bench 4.0 Removed from the Index: GDPval-AA v2.1, SciCode, and AA-LCR v1.1 Key results: ➤ Claude Opus 5.5 (max) leads at 58, ahead of GPT-6 Astra (max, 57) and GPT-6.1 Sol (max, 55): Anthropic and OpenAI hold the top five models. Gemini 4 Argon (high) is next at 50 ➤ The open weights gap widens from 3 points to 12: Kimi K3.1 Pro (weights not yet released) is the top open weights model at 46. Among released weights, DeepSeek V4.1 Flash 1017 (max) and GLM-5.3 (max) lead at 32 - 26 points behind the leader and below Claude Haiku 5.5 (max, 36) ➤ Cost per task varies by more than 13x among the leading models: of the 10 highest-scoring models shown, GPT-6.1 Terra (max) is the cheapest at $0.96 per Intelligence Index task and Claude Fable 5.1 (max) the most expensive at $13.04

Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences. https://www.anthropic.com/research/early-progress-drug-development